4.5 Article

Analytical validation of urine ALCAM ELISA as a test for lupus nephritis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM

Rongwei Lei et al.

Summary: This study demonstrates the potential of using lateral flow assays to test urinary ALCAM for the diagnosis of active lupus nephritis. The results show high accuracy in distinguishing ALN from healthy controls and other lupus patients. Periodic monitoring of uALCAM using this easy-to-use test could help in early detection of renal involvement or disease flares in lupus patients.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus

Samar A. Soliman et al.

Summary: This study evaluated the performance of ten urine protein markers in distinguishing disease activity in childhood-onset Systemic Lupus Erythematosus (cSLE). The results showed that urinary ALCAM, PF4, and VCAM-1 are potential biomarkers for predicting kidney disease activity in cSLE, and they hold potential as surrogate markers of nephritis flares in these patients.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Comprehensive Urinomic Identification of Protein Alternatives to Creatinine Normalization for Diagnostic Assessment of Lupus Nephritis

Sanam Soomro et al.

Summary: This study conducted a proteomic screen in lupus nephritis patients and identified urine proteins that are correlated with creatinine and not affected by the disease, particularly urine HVEM which can be used as an alternative to creatinine for biomarker normalization, facilitating the monitoring of lupus nephritis progression.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses

Samantha A. Chalmers et al.

Summary: CD6/ALCAM pathway plays a crucial role in the pathogenesis of lupus nephritis (LN) and systemic lupus erythematosus (SLE), contributing to T cell activation and trafficking. Furthermore, uALCAM is a potential biomarker for active renal involvement in SLE, independent of ethnicity.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Biochemical Research Methods

Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery Study

Tianfu Wu et al.

JOURNAL OF PROTEOME RESEARCH (2016)

Article Biochemical Research Methods

Urinary Angiostatin - A Novel Putative Marker of Renal Pathology Chronicity in Lupus Nephritis

Tianfu Wu et al.

MOLECULAR & CELLULAR PROTEOMICS (2013)

Review Rheumatology

Biomarkers in systemic lupus erythematosus: challenges and prospects for the future

Chau-Ching Liu et al.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2013)

Article Multidisciplinary Sciences

Metabolic Disturbances Associated with Systemic Lupus Erythematosus

Tianfu Wu et al.

PLOS ONE (2012)

Article Biochemical Research Methods

Serum Protein Profiling of Systemic Lupus Erythematosus and Systemic Sclerosis Using Recombinant Antibody Microarrays

Anders Carlsson et al.

MOLECULAR & CELLULAR PROTEOMICS (2011)

Article Immunology

SLE diagnosis and treatment: When early is early

Andrea Doria et al.

AUTOIMMUNITY REVIEWS (2010)

Review Biotechnology & Applied Microbiology

Biomarkers for Lupus Nephritis: A Critical Appraisal

Chi Chiu Mok

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)

Article Immunology

Preventive strategies in systemic lupus erythematosus

Andrea Doria et al.

AUTOIMMUNITY REVIEWS (2008)

Article Medicine, General & Internal

Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995

MM Ward

ARCHIVES OF INTERNAL MEDICINE (2000)